---
title: "Tellgen released its 2024 annual performance, with a net profit attributable to the parent company of 34.535 million yuan, a decrease of 61.37%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236608209.md"
description: "Tellgen released its 2024 annual report, with operating revenue of 437 million yuan, a year-on-year decrease of 19.53%; net profit attributable to shareholders of the parent company was 34.535 million yuan, a year-on-year decline of 61.37%; net profit excluding non-recurring gains and losses was 25.9648 million yuan, a year-on-year decrease of 59.24%. Basic earnings per share were 0.213 yuan, and it plans to distribute a cash dividend of 1.50 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-18T15:17:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236608209.md)
  - [en](https://longbridge.com/en/news/236608209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236608209.md)
generator: "portal-rs"
---

# Tellgen released its 2024 annual performance, with a net profit attributable to the parent company of 34.535 million yuan, a decrease of 61.37%

According to the Zhitong Finance APP, Tellgen (300642.SZ) released its annual report for 2024, reporting an operating income of 437 million yuan, a year-on-year decrease of 19.53%. The net profit attributable to shareholders of the listed company was 34.535 million yuan, a year-on-year decrease of 61.37%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.9648 million yuan, a year-on-year decrease of 59.24%. The basic earnings per share were 0.213 yuan. In addition, it plans to distribute a cash dividend of 1.50 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [300642.CN](https://longbridge.com/en/quote/300642.CN.md)

## Related News & Research

- [Monte dei Paschi flags availability of related-party transaction information document](https://longbridge.com/en/news/297237626.md)
- [Pharmaron Beijing announces extraordinary general meeting, H share class meeting](https://longbridge.com/en/news/296918409.md)
- [08:36 ETChoose Health Launches Most Comprehensive At-Home Liver Function Test with 20+ Biomarkers and Clinical Risk Scores](https://longbridge.com/en/news/297326666.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)
- [23:04 ETShinsung Materials Strengthens Competitiveness in the Functional Cosmetics Market with Differentiated Ingredient Technologies](https://longbridge.com/en/news/297116733.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**